MedPath

ONCOR: Dutch cardio-oncology registry

Recruiting
Conditions
Patients who will be-, are-, or have been treated with potential cardiotoxic oncological treatment and therefore a referred to specialized cardio-oncology units.
Registration Number
NL-OMON25455
Lead Sponsor
niversity Medical Center Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
2000
Inclusion Criteria

Patients who visit a specialized cardio-oncology unit.
- Age =18 years.
- Willing and able to provide written informed consent for participation

Exclusion Criteria

- Conditions that affect a patient’s ability to provide written informed consent, such as psychiatric or mental disorders, language barriers or other factors

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiovascular toxicity
Secondary Outcome Measures
NameTimeMethod
Changes in oncological treatment due to cardiovascular toxicity; Major Adverse Cardiovascular Events; All-cause mortality;
© Copyright 2025. All Rights Reserved by MedPath